Naphazoline / Hypromellose
萘甲唑啉/羟丙甲基纤维素
Report date: 2025/07/30 14:53:37
Base Information
Drug NameNaphazoline / Hypromellose
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsYes Naphazoline HydrochlorideHypromellose
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesLaboratorios Sophia Sa De Cv
China Registration ClassN/A
Develop Information
Active CompaniesLaboratorios Sophia Sa De Cv
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A